NCT00405353View on ClinicalTrials.gov

Testosterone Treatment for Multiple Sclerosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Multiple Sclerosis
Interventions
DRUG

Androgel 10 grams of gel containing 100 mg of testosterone

testosterone gel

Trial Locations (1)

90095

University of California, Los Angeles, Los Angeles

All Listed Sponsors
collaborator

National Multiple Sclerosis Society

OTHER

lead

University of California, Los Angeles

OTHER

NCT00405353 - Testosterone Treatment for Multiple Sclerosis | Biotech Hunter | Biotech Hunter